Health1 month ago
AstraZeneca’s Tagrisso Trial Shows Significant Survival Benefits
AstraZeneca has announced promising results from a late-stage clinical trial that demonstrates the effectiveness of its cancer treatment, Tagrisso (osimertinib), when used in conjunction with pemetrexed...